Patheon IncTSX: PTI

Patheon Amends Credit Facilities

· Issued by Patheon Inc via CNW
TORONTO, July 31 /CNW/ - Patheon Inc. (TSX: PTI) today announced that it
reached agreement with its lenders under its North American credit facilities
to amend the credit agreement following the Company's announcement on July 24,
2006 with respect to its Q3 results. In the coming weeks, the Company will
also be discussing with its lenders further amendments that give the Company
more financial flexibility as its implements its previously announced
performance enhancement program.

About Patheon
Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing 6,100 people and serving a client base of more
than 200 pharmaceutical and biotechnology companies.

Forward-Looking Statements
This news release contains forward-looking statements with respect to
Patheon, including its business operations and strategy and financial
performance and condition. Although management believes that the expectations
reflected in such forward-looking statements are reasonable, such statements
involve risks and uncertainties. Actual results may differ materially from
those expressed or implied by such forward-looking statements. Factors that
could cause actual results to differ materially from expectations include, but
are not limited to, currency fluctuations, the level of outsourcing services
required by the pharmaceutical companies (and in particular our clients), the
impact of changes in pharmaceutical development and manufacturing regulations
and general economic and market factors (including inflation and changes in
laws) and other factors discussed in materials filed with applicable
securities regulatory authorities from time to time.

%SEDAR: 00001700E

Patheon Inc on 6ix

Earlier from Patheon

Later from Patheon

All Patheon news releases